Drug firms’ eligibility for innovative pharmaceutical firms to be assessed

Published: 2012-04-10 06:59:00

Updated: 2012-04-10 06:59:00

The Ministry of Health and Welfare and the Korea Health Industry Development Institute are expected to step in and designate 50 innovative pharmaceutical firms as the applications begins from today and last until May 4.

To offer a total of 146 billion won, the ministry will strictly screen the...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK